<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="241">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT00798057</url>
  </required_header>
  <id_info>
    <org_study_id>UFPTI 0701-PI01</org_study_id>
    <nct_id>NCT00798057</nct_id>
  </id_info>
  <brief_title>Proton Radiation Therapy for Pituitary Adenoma</brief_title>
  <acronym>PI01</acronym>
  <official_title>Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information from medical records to see what effects
      proton beam radiation has on pituitary tumors and analyze possible side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data collection will be obtained from the patient's medical records including initial
      evaluation, pathology report, dosimetry information, radiotherapy completion records and
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">October 2051</completion_date>
  <primary_completion_date type="Anticipated">October 2041</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Collect and analyze outcome data on tumor control.</measure>
    <time_frame>When each patient has been followed for a minimum or 12 months and then again after 24 months to a maximum of 10 years.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collect and analyze outcome data on normal tissue morbidity.</measure>
    <time_frame>When each patient has been followed for a minimum of 12 months and then again after 24 months to a maximum of 10 years.</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pituitary Adenoma</condition>
  <arm_group>
    <arm_group_label>Proton Radiation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated at a radiation oncology clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically proven pituitary adenoma.

          -  Age 18 years or older.

          -  Status post biopsy, gross total resection (from initial surgery for recurrent
             disease) or subtotal resection.

          -  Good to moderate neurological function status

        Exclusion Criteria:

        *Previous radiation that would compromise the ability to deliver the prescribed treatment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S Malyapa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida Proton Therapy Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Intake Coordinator</last_name>
    <phone>877-686-6009</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida Proton Therapy Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Intake Coordinator</last_name>
      <phone>877-686-6009</phone>
    </contact>
    <investigator>
      <last_name>Robert S Malyapa, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.floridaproton.org/contact/contact.html</url>
    <description>Contact the University of Florida Proton Therapy Institute</description>
  </link>
  <reference>
    <citation>Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004 Aug 1;101(3):613-9. Review.</citation>
    <PMID>15274075</PMID>
  </reference>
  <reference>
    <citation>Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999 Jan;1(1):14-25.</citation>
    <PMID>11554386</PMID>
  </reference>
  <reference>
    <citation>Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol (Oxf). 1999 Sep;51(3):281-4.</citation>
    <PMID>10469006</PMID>
  </reference>
  <reference>
    <citation>Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf). 1993 Jun;38(6):571-8.</citation>
    <PMID>8334743</PMID>
  </reference>
  <reference>
    <citation>Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1279-86.</citation>
    <PMID>11483339</PMID>
  </reference>
  <reference>
    <citation>Stieber V, Deguzman A, et al. Pituitary. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams and Wilkins; 2004. p.839-859.</citation>
  </reference>
  <reference>
    <citation>Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2005 Feb;90(2):800-4. Epub 2004 Nov 23.</citation>
    <PMID>15562021</PMID>
  </reference>
  <reference>
    <citation>Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol. 2003 Jul;68(1):1-14.</citation>
    <PMID>12885446</PMID>
  </reference>
  <reference>
    <citation>Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol. 2001 Dec;61(3):287-97.</citation>
    <PMID>11730999</PMID>
  </reference>
  <reference>
    <citation>Cozzi L, Clivio A, Vanetti E, Nicolini G, Fogliata A. Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol. 2006 Jul;182(7):376-81.</citation>
    <PMID>16826355</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 9, 2013</lastchanged_date>
  <firstreceived_date>November 24, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pituitary tumor</keyword>
  <keyword>Outcomes</keyword>
  <keyword>Proton radiation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
